Literature DB >> 19217621

Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.

J R Hamilton1, I Cornelissen, J K Mountford, S R Coughlin.   

Abstract

Platelet activation has long been postulated to contribute to the development of atherosclerotic plaques, although the mechanism by which this might occur remains unknown. Thrombin is a potent platelet activator and transfusion of thrombin-activated platelets into mice increases plaque formation, suggesting that thrombin-induced platelet activation might contribute to platelet-dependent atherosclerosis. Platelets from protease-activated receptor 4-deficient (Par4-/-) mice fail to respond to thrombin. To determine whether thrombin-activated platelets play a necessary role in a model of atherogenesis, we compared plaque formation and progression in Par4+/+ and Par4-/- mice in the atherosclerosis-prone apolipoprotein E-deficient (ApoE-/-) background. Littermate Par4+/+ and Par4-/- mice, all ApoE-/-, were placed on a Western diet (21% fat, 0.15% cholesterol) for 5 or 10 weeks. The percent of aortic lumenal surface covered by plaques in Par4+/+ and Par4-/- mice was not different at either time point (2.2+/-0.3% vs. 2.5+/-0.2% and 5.1+/-0.4% vs. 5.6+/-0.4% after 5 and 10 weeks, respectively). Further, no differences were detected in the cross-sectional area of plaques measured at the aortic root (1.53+/-0.17 vs. 1.66+/-0.16x10(5)microm(2) and 12.56+/-1.23 vs. 13.03+/-0.55x10(5)microm(2) after 5 and 10 weeks, respectively). These findings indicate that thrombin-mediated platelet activation is not required for the early development of atherosclerotic plaques in the ApoE-/- mouse model and suggest that, if platelet activation is required for plaque formation under these experimental conditions, platelet activators other than thrombin suffice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217621      PMCID: PMC2717183          DOI: 10.1016/j.atherosclerosis.2009.01.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

1.  Platelet-mediated lymphocyte delivery to high endothelial venules.

Authors:  T G Diacovo; K D Puri; R A Warnock; T A Springer; U H von Andrian
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

Review 2.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

Authors:  M J Davies
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

3.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.

Authors:  M I Furman; S E Benoit; M R Barnard; C R Valeri; M L Borbone; R C Becker; H B Hechtman; A D Michelson
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

4.  Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

Authors:  L Boring; J Gosling; M Cleary; I F Charo
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

5.  CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia.

Authors:  Valerio Sanguigni; Domenico Ferro; Pasquale Pignatelli; Maria Del Ben; Tini Nadia; Mirella Saliola; Roberto Sorge; Francesco Violi
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

6.  Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb.

Authors:  Steffen Massberg; Katrin Schürzinger; Michael Lorenz; Ildiko Konrad; Christian Schulz; Nikolaus Plesnila; Elisabeth Kennerknecht; Martina Rudelius; Susanne Sauer; Siegmund Braun; Elisabeth Kremmer; Nikla R Emambokus; Jon Frampton; Meinrad Gawaz
Journal:  Circulation       Date:  2005-08-15       Impact factor: 29.690

7.  Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.

Authors:  K Brand; C L Banka; N Mackman; R A Terkeltaub; S T Fan; L K Curtiss
Journal:  Arterioscler Thromb       Date:  1994-05

8.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

Authors:  S H Zhang; R L Reddick; B Burkey; N Maeda
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages.

Authors:  H Wada; T Kaneko; Y Wakita; K Minamikawa; S Nagaya; S Tamaki; K Deguchi; S Shirakawa
Journal:  Int J Cardiol       Date:  1994-12       Impact factor: 4.164

10.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.

Authors:  R A Shivdasani; M F Rosenblatt; D Zucker-Franklin; C W Jackson; P Hunt; C J Saris; S H Orkin
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

View more
  10 in total

Review 1.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

2.  PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Authors:  Shannon M Jones; Adrien Mann; Kelsey Conrad; Keith Saum; David E Hall; Lisa M McKinney; Nathan Robbins; Joel Thompson; Abigail D Peairs; Eric Camerer; Katey J Rayner; Michael Tranter; Nigel Mackman; A Phillip Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

3.  The anti-platelet effects of apocynin in mice are not mediated by inhibition of NADPH oxidase activity.

Authors:  Janahan Dharmarajah; Jane F Arthur; Christopher G Sobey; Grant R Drummond
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-01       Impact factor: 3.000

Review 4.  Protease-activated receptor 4: from structure to function and back again.

Authors:  Shauna L French; Justin R Hamilton
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

Review 5.  Thrombin generation and atherosclerosis.

Authors:  Jana Kalz; Hugo ten Cate; Henri M H Spronk
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

Review 6.  Platelets and their chemokines in atherosclerosis-clinical applications.

Authors:  Philipp von Hundelshausen; Martin M N Schmitt
Journal:  Front Physiol       Date:  2014-08-08       Impact factor: 4.566

Review 7.  Platelets Are at the Nexus of Vascular Diseases.

Authors:  Héloïse Lebas; Katia Yahiaoui; Raphaël Martos; Yacine Boulaftali
Journal:  Front Cardiovasc Med       Date:  2019-09-11

8.  The necroptotic cell death pathway operates in megakaryocytes, but not in platelet synthesis.

Authors:  Diane Moujalled; Pradnya Gangatirkar; Maria Kauppi; Jason Corbin; Marion Lebois; James M Murphy; Najoua Lalaoui; Joanne M Hildebrand; John Silke; Warren S Alexander; Emma C Josefsson
Journal:  Cell Death Dis       Date:  2021-01-28       Impact factor: 8.469

Review 9.  Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives.

Authors:  Lei Wang; Chaojun Tang
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

10.  Protein Kinase Cθ Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis.

Authors:  Somasundaram Raghavan; Nikhlesh K Singh; Sivaiah Gali; Arul M Mani; Gadiparthi N Rao
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.